NATASHA ANANDANI: Open Payments
NPI 1144724923 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,791 in 145 payments from 22 companies in 2025. Trend: 2023 $2,050 · 2024 $2,505 · 2025 $7,791
Speaker / faculty: $4,431Food & beverage: $3,301Consulting: $59
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 26 | $5,148 |
| ARS Pharmaceuticals Operations, Inc. | 29 | $568 |
| AstraZeneca Pharmaceuticals LP | 14 | $309 |
| GlaxoSmithKline, LLC. | 17 | $256 |
| BioCryst US Sales Co., LLC | 9 | $220 |
| Novartis Pharmaceuticals Corporation | 10 | $211 |
| CSL Behring | 5 | $190 |
| Genentech, Inc. | 1 | $148 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $143 |
| Organon LLC | 4 | $127 |
Products named: DUPIXENT, NEFFY, ORLADEYO, XOLAIR, TEZSPIRE, Hizentra, TRELEGY ELLIPTA, NUCALA.
Industry payments across NC — which companies pay providers there.
